W. Robert Taylor MD, PhD
Overview
Bob Taylor is a Professor of Medicine and Biomedical Engineering at Emory University School of Medicine. He is the Marcus Chair in Vascular Medicine, Executive Vice Chair of the Department of Medicine, and the Director of the Division of Cardiology at Emory.
Dr. Taylor received his MD, cum laude, from Harvard Medical School and his PhD in Physiology from The Johns Hopkins University. After completing his Internal Medicine Training at Harvard Medical School, Beth Israel Hospital in 1988, he came to the Emory University School of Medicine for subspecialty training in Cardiovascular Disease. Dr. Taylors research interests are focused in the area of vascular biology with an emphasis on vascular biomechanics, inflammation, and regenerative medicine. He is also the Emory PI for the NIH-funded Georgia CTSA. Studies carried out by his group include both laboratory-based studies and translational work in humans.
Academic Appointment
- Division Director, Department of Medicine, Division of Cardiology
- Executive Vice Chair, Department of Medicine, Emory University School of Medicine
- Marcus Chair in Vascular Medicine, Emory University
- Professor of Medicine, Division of Cardiology, Emory University
- Professor of Biomedical Engineering, Department of Biomedical Engineering, Emory University
- Member Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology
- Member of Graduate Division of Biological and Biomedical Sciences, Emory University
Education
Degrees
- MD from Harvard Medical School
- PhD from Johns Hopkins University
- BS from University of Maryland
Research
Focus
- The overall goal of the laboratory is to study the mechanisms and consequences of vascular inflammation. Specifically, we study: The Role of Angiotensin II in the Pathogenesis of Atherosclerosis; Mechanical Strain and Vascular Inflammation; Mechanisms of Angiogenesis; Advanced Glycation Endproducts and; Vascular Inflammation and Endothelial Progenitor Cells in Vascular Disease.
Publications
-
Is Laser Doppler Perfusion Imaging Trulya "Gold Standard" for Preclinical Peripheral Artery Disease Research?
JACC Basic Transl Sci Volume: 10 Page(s): 104 - 106
01/01/2025 Authors: Oh DG; Hansen L; Taylor WR -
Cellular communication network factor 2 regulates smooth muscle cell transdifferentiation and lipid accumulation in atherosclerosis.
Cardiovasc Res Volume: 120 Page(s): 2191 - 2207
12/31/2024 Authors: Xu Q; Sun J; Holden CM; Neto HCF; Wang T; Zhang C; Fu Z; Joseph G; Shi R; Wang J -
The Role of Fatty Acid Synthase in the Vascular Smooth Muscle Cell to Foam Cell Transition.
Cells Volume: 13
04/09/2024 Authors: Bogan BJ; Williams HC; Holden CM; Patel V; Joseph G; Fierro C; Sepulveda H; Taylor WR; Rezvan A; San Martin A -
Isothermal titration calorimetry analysis of the binding between the maltodextrin binding protein malE of Staphylococcus aureus with maltodextrins of various lengths.
Biochem Biophys Res Commun Volume: 695 Page(s): 149467
02/05/2024 Authors: Takemiya K; Wang S; Liu Y; Murthy N; Goodman MM; Taylor WR -
Accelerated atherosclerosis in beta-thalassemia.
Am J Physiol Heart Circ Physiol Volume: 325 Page(s): H1133 - H1143
11/01/2023 Authors: Hurtado J; Sellak H; Joseph G; Lewis CV; Naudin CR; Garcia S; Wodicka JR; Archer DR; Taylor WR -
Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis.
FASEB Bioadv Volume: 5 Page(s): 199 - 210
05/01/2023 Authors: Lewis CV; Sellak H; Sawan MA; Joseph G; Darby TM; VanInsberghe D; Naudin CR; Archer DR; Jones RM; Taylor WR -
Conserved miR-370-3p/BMP-7 axis regulates the phenotypic change of human vascular smooth muscle cells.
Sci Rep Volume: 13 Page(s): 2404
02/10/2023 Authors: Kim Y; Yu N; Jang YE; Lee E; Jung Y; Lee DJ; Taylor WR; Jo H; Kim J; Lee S -
A New Method for Quantifying Abdominal Aortic Wall Shear Stress Using Phase Contrast Magnetic Resonance Imaging and the Womersley Solution.
J Biomech Eng Volume: 144
09/01/2022 Authors: Iffrig E; Timmins LH; El Sayed R; Taylor WR; Oshinski JN -
Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice.
Lab Invest Volume: 102 Page(s): 805 - 813
08/01/2022 Authors: Lewis CV; Sellak H; Hansen L; Joseph G; Hurtado J; Archer DR; Jun H-W; Brown LA; Taylor WR -
Remuscularization with triiodothyronine and 1-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling.
Sci Rep Volume: 12 Page(s): 8852
05/25/2022 Authors: Bogush N; Tan L; Naqvi E; Calvert JW; Graham RM; Taylor WR; Naqvi N; Husain A